We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · November 01, 2021

Glycemic Control and Neonatal Outcomes With Glyburide, Metformin, or Insulin in Gestational Diabetes Mellitus

BMC Endocrine Disorders


Additional Info

BMC Endocrine Disorders
Glycemic control and neonatal outcomes in women with gestational diabetes mellitus treated using glyburide, metformin, or insulin: a pairwise and network meta-analysis
BMC Endocr Disord 2021 Oct 12;21(1)199, DQ Yu, GX Xu, XY Teng, JW Xu, LF Tang, C Feng, JP Rao, M Jin, LQ Wang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading